Literature DB >> 10818512

Which vascular lesions are of importance in vascular dementia?

M M Esiri1.   

Abstract

Most necropsy surveys of dementia have found that vascular disease is second only to Alzheimer's disease as a cause of dementia. Alzheimer's disease and cerebrovascular disease also often coexist. The purpose of the present study was to determine the nature of the cerebrovascular lesions that are most significant in producing dementia. These were analyzed in a group of cases of dementia in which only vascular pathology was present and, in particular, no more than trivial amounts of Alzheimer-type pathology were present. The cerebrovascular lesions in this group of cases were compared with those in a group of stroke cases who were nondemented and a group of elderly cases without stroke or dementia. Severe cribriform change and deep white/grey matter micro-infarcts were significantly more common in the test group than in either of the control groups, whereas single macroscopic infarcts were more common in the stroke control group than either of the other two groups. Thus, microvascular deep white and grey matter lesions, but not macroscopic infarction, were significant in vascular dementia. The results of this study will be discussed in relation to the view that microvascular lesions may also contribute to dementia in subjects with more extensive Alzheimer-type pathology and thus lower the threshold at which Alzheimer-type pathology becomes clinically manifest.

Entities:  

Mesh:

Year:  2000        PMID: 10818512     DOI: 10.1111/j.1749-6632.2000.tb06373.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Neuropathological investigation of dementia: a guide for neurologists.

Authors:  S Love
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

3.  Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.

Authors:  Susan K Lemieux; Carrie A Smith-Bell; Jered R Wells; Nnadozie M Ezerioha; Jeffrey S Carpenter; D Larry Sparks; Bernard G Schreurs
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

4.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

5.  Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy.

Authors:  A M Wessels; S Simsek; P L Remijnse; D J Veltman; G J Biessels; F Barkhof; P Scheltens; F J Snoek; R J Heine; S A R B Rombouts
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

6.  Walking difficulties in patients with Alzheimer's disease might originate from gait apraxia.

Authors:  S Della Sala; H Spinnler; A Venneri
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

7.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Impact of age-related neuroglial cell responses on hippocampal deterioration.

Authors:  Joseph O Ojo; Payam Rezaie; Paul L Gabbott; Michael G Stewart
Journal:  Front Aging Neurosci       Date:  2015-04-29       Impact factor: 5.750

9.  The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.

Authors:  Sharon C Yates; Amen Zafar; Erzsebet M Rabai; James B Foxall; Sheila Nagy; Karen E Morrison; Carl Clarke; Margaret M Esiri; Sharon Christie; A David Smith; Zsuzsanna Nagy
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

10.  Association of genetic risk for Alzheimer disease and hearing impairment.

Authors:  Willa D Brenowitz; Teresa J Filshtein; Kristine Yaffe; Stefan Walter; Sarah F Ackley; Thomas J Hoffmann; Eric Jorgenson; Rachel A Whitmer; M Maria Glymour
Journal:  Neurology       Date:  2020-09-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.